株式会社極東書店トップ > 商品一覧 > FDA and Intellectual Property Strategies for Medical Device Technologies: Including Artificial Intelligence, Software and Applications. Second Edition 2026
商品詳細
FDA and Intellectual Property Strategies for Medical Device Technologies: Including Artificial Intelligence, Software and Applications. Second Edition 2026
・ISBN 978-3-032-12648-1 hard EUR 119.99
¥32,072.- (税込) ※(※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
| 著者・編者 | Halt, Jr., Gerald B. / Donch, Jr., John C. / Stiles, Amber R. / Theiss, Brandon R. / Byrne, Michelle / Hodnick, William F. / Eldridge, Joshua / Goodman, Randy / Jenkins VanLuvanee, Lisa / Blue, Dana L., |
|---|---|
| 出版社 | (Springer Nature Switzerland AG, SZ) |
| 出版年月 | 2026 |
| ページ数 | 410 pp. |
| 言語 | ENG |
| ニュース番号 | <A05-4499> |
解説
This book offers comprehensive, easy to understand guidance for medical device technology innovators on how to work through the United States Food and Drug Administration (US FDA) regulatory review and approval/grant/clearance process, while also providing insight on the various intellectual property concerns that many medical device innovators face. In the first portion of this book, readers are introduced to important concepts concerning FDA compliance for medical devices, as well as strategies for successfully navigating the FDA regulatory review and approval/grant/clearance process. Specifically, the first portion discusses the expansive range of medical devices and then walks through the most common routes to market: the PMA, 510(k), and De Novo application processes. The complexities of medical device commercialization in the US market are also discussed. Additionally, this book explores how Artificial Intelligence (AI) and new software innovations are impacting the medical regulatory space. In the second portion of this book, readers are introduced to the various types of intellectual property rights that are available for medical device technology inventions and innovations and can explore ways to overcome unique intellectual property challenges faced by many medical device technology innovators. In the third portion of the book, specific strategies are discussed to navigate the interface between the FDA regulatory process and the process of obtaining intellectual property protection.
This book also includes a number of descriptive examples, case studies, and scenarios to illustrate the topics discussed and is intended for use by medical device designers, developers, and innovators.